Click Here for 5% Off Your First Aladdin Purchase!

Iberdomide (CC220) - 97%, high purity , CAS No.1323403-33-3, cereblon

  • Moligand™
  • ≥97%
Item Number
I414161
Grouped product items
SKUSizeAvailabilityPrice Qty
I414161-2mg
2mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$68.90
I414161-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$117.90
I414161-10mg
10mg
In stock
$206.90
I414161-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$414.90
I414161-50mg
50mg
In stock
$741.90
I414161-100mg
100mg
In stock
$1,175.90

E3 ligase Ligand

View related series
cereblon

Basic Description

SynonymsIberdomide|1323403-33-3|cc-220|(S)-3-(4-((4-(Morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione|Iberdomide [USAN]|CC220|8V66F27X44|(3s)-3-[4-({4-[(Morpholin-4-Yl)methyl]phenyl}methoxy)-1-Oxo-1,3-Dihydro-2h-Isoindol-2-Yl]piperidine-2,6-
Specifications & Purity97%
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Mechanism of actioncereblon
Product Description

Information

Iberdomide (CC-220) is a novel oral immunomodulatory compound that targets cereblon , part of the CRL4CRBN E3 ubiquitin ligase complex, with an IC50 of 60 nM in a competitive TR-FRET assay. Iberdomide (CC-220) induces apoptosis with antitumor and immunostimulatory activities.


Targets

cereblon 60 nM


In vitro

In cellular degradation assays, treatment with CC-220 results in the loss of Ikaros protein levels with an EC50 of 1 nM compared to 67 nM for lenalidomide and 24 nM for pomalidomide. CC-220 is similarly potent toward Aiolos, with an EC50 of 0.5 nM compared to 87 nM for lenalidomide and 22 nM for pomalidomide. CC-220 is a potent anti-proliferative and pro-apoptotic compound that shows activity in several MM cell line categories with differing sensitivity to lenalidomide, pomalidomide and dexamethasone. CC-220 induces PBMC-mediated killing of all MM cell lines regardless of the level of Cereblon expression and cell autonomous sensitivity. CC-220 acts through binding of Cereblon, leading to the degradation of the hematopoietic transcription factors Ikaros and Aiolos, followed by disruption of the MM promoting c-Myc/IRF4 axis.

Product Properties

ALogP1.56
HBD Count1
Rotatable Bond6

Associated Targets

CRBN Tclin Protein cereblon 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (3S)-3-[7-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione
INCHI InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1
InChi Key IXZOHGPZAQLIBH-NRFANRHFSA-N
Canonical SMILES C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5
Isomeric SMILES C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5
Alternate CAS 1323403-33-3
PubChem CID 67335295
MeSH Entry Terms (3S)-3-(4-((4-((morpholin-4-yl)methyl)phenyl)methoxy)-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;CC-220;CC-220 hydrochloride;CC220;iberdomide;iberdomide hydrochloride
Molecular Weight 449.5

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
G2227946Certificate of AnalysisJun 12, 2022 I414161
G2227947Certificate of AnalysisJun 12, 2022 I414161
G2227948Certificate of AnalysisJun 12, 2022 I414161

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 90 mg/mL (200.22 mM); Ethanol: 4 mg/mL (8.89 mM); Water: Insoluble;
SensitivityLight sensitive
DMSO(mg / mL) Max Solubility90
DMSO(mM) Max Solubility200.222469410456
Water(mg / mL) Max Solubility<1

Related Documents

References

1. Cai X, Qiao Y, Diao C, Xu X, Chen Y, Du S, Liu X, Liu N, Yu S, Chen D et al..  (2014)  Association between polymorphisms of the IKZF3 gene and systemic lupus erythematosus in a Chinese Han population..  PLoS ONE,  (10): (e108661).  [PMID:25271777]
2. Bjorklund CC, Lu L, Kang J, Hagner PR, Havens CG, Amatangelo M, Wang M, Ren Y, Couto S, Breider M et al..  (2015)  Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4..  Blood Cancer J,  (3): (e354).  [PMID:26430725]
3. Matyskiela ME, Zhang W, Man HW, Muller G, Khambatta G, Baculi F, Hickman M, LeBrun L, Pagarigan B, Carmel G et al..  (2018)  A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos..  J Med Chem,  61  (2): (535-542).  [PMID:28425720]

Solution Calculators